ChargePoint Acquires Assets of Forac - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ChargePoint Acquires Assets of Forac


ChargePoint Technology, a UK-based manufacturer and supplier of precision containment valves to the pharmaceutical and chemical industries, announced that it has acquired the assets of Forac Limited, a key business in its supply chain.

Under the deal, ChargePoint will have access to a compact pneumatic actuator used to open and close the isolation valves that feature in production processes used by the pharmaceutical, food and fuel industries. No financial terms were disclosed.

Forac will relocate its plant and stock from a base in Shoreham-by-Sea, West Sussex to ChargePoint’s manufacturing plant in Speke, Merseyside. Founder and managing director of Forac Adam Bunyard has joined ChargePoint as part of the deal.

ChargePoint’s containment valves are used for the safe and sterile handling of powders in manufacturing processes, for example when making drugs in tablet form. The valves enable safe transferring of powders from one vessel to another during the production process. By minimizing dust emissions, they are specified to prevent cross-contamination and protect operators from exposure to potent substances.

Source: ChargePoint 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here